A phase 3, double-blind, randomized study of pamiparib versus placebo as maintenance therapy in patients with inoperable, locally advanced, or metastatic gastric cancer that responded to platinum-based first-line chemotherapy - Trial in progress

  1. Ciardiello, F.
  2. Bang, Y.
  3. Bendell, J.
  4. Cervantes, A.
  5. Brachmann, R.
  6. Zhang, Y.
  7. Raponi, M.
  8. Farin, H.
  9. Shen, L.
Revista:
Annals of oncology : official journal of the European Society for Medical Oncology

ISSN: 1569-8041

Año de publicación: 2018

Volumen: 29

Páginas: v25-v26

Tipo: Artículo

DOI: 10.1093/ANNONC/MDY151.093 GOOGLE SCHOLAR lock_openAcceso abierto editor